BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28805979)

  • 21. The Role of SGLT2 Inhibitor Ipragliflozin on Cardiac Hypertrophy and microRNA Expression Profiles in a Non-diabetic Rat Model of Cardiomyopathy.
    Takasu T
    Biol Pharm Bull; 2022; 45(9):1321-1331. PubMed ID: 36047201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of rat-induced pluripotent stem cells from a new model of metabolic syndrome.
    Takenaka-Ninagawa N; Kawabata Y; Watanabe S; Nagata K; Torihashi S
    PLoS One; 2014; 9(8):e104462. PubMed ID: 25111735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological inhibition of the lipid phosphatase PTEN ameliorates heart damage and adipose tissue inflammation in stressed rats with metabolic syndrome.
    Ashikawa S; Komatsu Y; Kawai Y; Aoyama K; Nakano S; Cui X; Hayakawa M; Sakabe N; Furukawa N; Ikeda K; Murohara T; Nagata K
    Physiol Rep; 2022 Jan; 10(1):e15165. PubMed ID: 35005845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fat Quality Matters: Distinct Proteomic Signatures Between Lean and Obese Cardiac Visceral Adipose Tissue Underlie its Differential Myocardial Impact.
    Conceição G; Matos J; Miranda-Silva D; Gonçalves N; Sousa-Mendes C; Gonçalves A; Ferreira R; Leite-Moreira AF; Vitorino R; Falcão-Pires I
    Cell Physiol Biochem; 2020 Apr; 54(3):384-400. PubMed ID: 32319743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction.
    Buss SJ; Muenz S; Riffel JH; Malekar P; Hagenmueller M; Weiss CS; Bea F; Bekeredjian R; Schinke-Braun M; Izumo S; Katus HA; Hardt SE
    J Am Coll Cardiol; 2009 Dec; 54(25):2435-46. PubMed ID: 20082935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.
    Park SH; Farooq MA; Gaertner S; Bruckert C; Qureshi AW; Lee HH; Benrahla D; Pollet B; Stephan D; Ohlmann P; Lessinger JM; Mayoux E; Auger C; Morel O; Schini-Kerth VB
    Cardiovasc Diabetol; 2020 Feb; 19(1):19. PubMed ID: 32070346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease.
    Temmerman F; Chen F; Libbrecht L; Vander Elst I; Windmolders P; Feng Y; Ni Y; De Smedt H; Nevens F; van Pelt J
    World J Gastroenterol; 2017 Aug; 23(30):5499-5507. PubMed ID: 28852309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-[(18)F]fluoro-2-deoxy-D-glucose combined with microdialysis can be used for the comparison of tissue glucose metabolism in obese and lean rats.
    Virtanen KA; Haaparanta M; Grönroos T; Bergman J; Solin O; Rouru J; Nuutila P; Huupponen R
    Diabetes Obes Metab; 2002 Jan; 4(1):60-8. PubMed ID: 11874444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome.
    Maggio AB; Mueller P; Wacker J; Viallon M; Belli DC; Beghetti M; Farpour-Lambert NJ; McLin VA
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):720-6. PubMed ID: 22157928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.
    Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V
    Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diazoxide enhances adipose tissue protein kinase B activation and glucose transporter-4 expression in obese Zucker rats.
    Alemzadeh R; Zhang J; Tushaus K; Koontz J
    Med Sci Monit; 2004 Mar; 10(3):BR53-60. PubMed ID: 14976464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptive responses of enzymes of carbohydrate and lipid metabolism to dietary alteration in genetically obese Zucker rats (fa/fa).
    Spydevold SO; Greenbaum AL; Baquer NZ; McLean P
    Eur J Biochem; 1978 Sep; 89(2):329-39. PubMed ID: 710395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular adaptations of adipose tissue to 6 weeks of morning fasting vs. daily breakfast consumption in lean and obese adults.
    Gonzalez JT; Richardson JD; Chowdhury EA; Koumanov F; Holman GD; Cooper S; Thompson D; Tsintzas K; Betts JA
    J Physiol; 2018 Feb; 596(4):609-622. PubMed ID: 29193093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of 2-deoxy-D-glucose on brown adipose tissue of lean and obese Zucker rats.
    Allars J; York DA
    Int J Obes; 1986; 10(2):147-58. PubMed ID: 3721700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age and obesity-associated changes in the expression and activation of components of the AMPK signaling pathway in human right atrial tissue.
    Niemann B; Pan R; Teschner M; Boening A; Silber RE; Rohrbach S
    Exp Gerontol; 2013 Jan; 48(1):55-63. PubMed ID: 22546364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonreceptor-mediated responses of adenylate cyclase in membranes from liver, muscle, and white and brown adipose tissue of obese (fa/fa) and lean (Fa/) Zucker rats.
    Naim M; Katz Y; Brand JG; Kare MR
    Proc Soc Exp Biol Med; 1990 Dec; 195(3):369-74. PubMed ID: 2175438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Göttingen minipigs.
    Renner S; Blutke A; Dobenecker B; Dhom G; Müller TD; Finan B; Clemmensen C; Bernau M; Novak I; Rathkolb B; Senf S; Zöls S; Roth M; Götz A; Hofmann SM; Hrabĕ de Angelis M; Wanke R; Kienzle E; Scholz AM; DiMarchi R; Ritzmann M; Tschöp MH; Wolf E
    Mol Metab; 2018 Oct; 16():180-190. PubMed ID: 30017782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats.
    Festuccia WT; Blanchard PG; Belchior T; Chimin P; Paschoal VA; Magdalon J; Hirabara SM; Simões D; St-Pierre P; Carpinelli A; Marette A; Deshaies Y
    Am J Physiol Endocrinol Metab; 2014 May; 306(9):E1046-54. PubMed ID: 24619883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mTORC1 inhibition with rapamycin exacerbates adipose tissue inflammation in obese mice and dissociates macrophage phenotype from function.
    Paschoal VA; Amano MT; Belchior T; Magdalon J; Chimin P; Andrade ML; Ortiz-Silva M; Castro É; Yamashita AS; Rosa Neto JC; Câmara NO; Festuccia WT
    Immunobiology; 2017 Feb; 222(2):261-271. PubMed ID: 27692982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.